NASDAQ:CELZ • US22529Y4089
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CREATIVE MEDICAL TECHNOLOGY (CELZ).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-02-25 | Roth Capital | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9K -90.00% | 11K 22.22% | 6K -45.45% | -100.00% | 34.507M | 61.282M 77.59% | 84.628M 38.10% | 102.85M 21.53% | 119.26M 15.96% | |
| EBITDA YoY % growth | -5.526M 45.56% | -5.633M -1.95% | -6.02M -6.85% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.62M 45.12% | -5.744M -2.20% | -6.143M -6.94% | -5.735M 6.63% | -5.881M -2.54% | 36.862M 726.76% | 53.055M 43.93% | 65.653M 23.75% | 76.981M 17.25% | |
| Operating Margin | -62,445.56% | -52,217.27% | -102,380.00% | N/A | -17.04% | 60.15% | 62.69% | 63.83% | 64.55% | |
| EPS YoY % growth | -3.69 62.35% | -3.71 -0.54% | N/A 43.91% | -1.43 31.37% | -1.38 3.57% | 3.74 371.85% | 4.88 30.25% | 5.89 20.71% | 6.73 14.38% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
7 analysts have analysed CELZ and the average price target is 20.4 USD. This implies a price increase of 844.44% is expected in the next year compared to the current price of 2.16.
CREATIVE MEDICAL TECHNOLOGY (CELZ) will report earnings on 2026-05-07.
The consensus rating for CREATIVE MEDICAL TECHNOLOGY (CELZ) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.